Primary thromboembolism prophylaxis in outpatient cancer patients receiving chemotherapy

被引:0
|
作者
Draeger, Desiree L. [1 ,2 ]
机构
[1] Univ Med Rostock, Klin & Poliklin Urol, Schillingallee 35, D-18057 Rostock, Germany
[2] Deutsch Gesell Urol, UroEvidence DGU, Berlin, Germany
来源
UROLOGIE | 2024年
关键词
VENOUS THROMBOEMBOLISM; PREVENTION;
D O I
10.1007/s00120-024-02273-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [31] Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy
    Kitano, Toshiyuki
    Tada, Harue
    Nishimura, Tsutomu
    Teramukai, Satoshi
    Kanai, Masashi
    Nishimura, Takafumi
    Misawa, Akiko
    Yoshikawa, Kiyotsugu
    Yasuda, Hiroyasu
    Ishiguro, Hiroshi
    Matsumoto, Shigemi
    Yanagihara, Kazuhiro
    Fukushima, Masanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (01) : 37 - 41
  • [32] Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy
    Toshiyuki Kitano
    Harue Tada
    Tsutomu Nishimura
    Satoshi Teramukai
    Masashi Kanai
    Takafumi Nishimura
    Akiko Misawa
    Kiyotsugu Yoshikawa
    Hiroyasu Yasuda
    Hiroshi Ishiguro
    Shigemi Matsumoto
    Kazuhiro Yanagihara
    Masanori Fukushima
    International Journal of Hematology, 2007, 86 : 37 - 41
  • [33] Primary Prophylaxis of Venous Thromboembolism in Ambulatory Cancer Patients Treated with Antineoplastics
    Groupe Francophone Thrombose et Cancer
    ONCOLOGIE, 2016, 18 (01) : 23 - 31
  • [34] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
    Ricardo Fernandes
    Sasha Mazzarello
    Carol Stober
    Lisa Vandermeer
    Shaan Dudani
    Mohamed F. K. Ibrahim
    Habeeb Majeed
    Kirstin Perdrizet
    Risa Shorr
    Brian Hutton
    Dean Fergusson
    Mark Clemons
    Breast Cancer Research and Treatment, 2017, 161 : 1 - 10
  • [35] Application of thromboelastography parameters for the prediction of venous thromboembolism in cancer patients receiving chemotherapy
    Sukhanov, V. A.
    Petrova, O. Y.
    THROMBOSIS RESEARCH, 2014, 133 : S203 - S203
  • [36] Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer.
    Basaran, Derman
    Suhner, Jessa
    Sassine, Dib
    Boerner, Thomas
    Liu, Ying L.
    Grisham, Rachel N.
    Tew, William P.
    Gardner, Ginger J.
    Zivanovic, Oliver
    Sonoda, Yukio
    Long-Roche, Kara C.
    Chi, Dennis
    Soff, Gerald A.
    Jewell, Elizabeth Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy
    Kuderer, N. M.
    Francis, C. W.
    Culakova, E.
    Khorana, A. A.
    Ortel, T.
    Falanga, A.
    Lyman, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Primary Prophylaxis of Venous Thromboembolism in Surgical Patients
    Rawat, Anish
    Huynh, Taro T.
    Peden, Eric K.
    Kougias, Panagiotis
    Lin, Peter H.
    VASCULAR AND ENDOVASCULAR SURGERY, 2008, 42 (03) : 205 - 216
  • [39] Prophylaxis of venous thromboembolism in patients with cancer
    Chojnowski, Krzysztof
    Trelinski, Jacek
    ONCOLOGY IN CLINICAL PRACTICE, 2012, 8 (03): : 105 - 112
  • [40] Prophylaxis of venous thromboembolism in cancer patients
    Frere, Corinne
    Doucet, Ludovic
    Farge, Dominique
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 535 - 539